|
|
|
| Serum BDNF, MIF, EGF Levels and their Correlation with Cognitive Function in Patients with Schizophrenia |
| GUO Jun, LI Ying |
| Shaanxi Weinan mental health center, Shaanxi Weinan 714026 |
|
|
|
|
Abstract 【Objective】To explore the serum brain-derived neurotrophic factor (BDNF), serum macrophage migration in-hibitory factor (MIF), epidermal growth factor (EGF) and their relationship with cognitive function in peripheral blood of schizophrenia. 【Methods】 The clinical data of 54 schizophrenic patients treated in our hospital from January 2017 to January 2019 (observation group) and 58 healthy volunteers in the same period (control group) were selected. The levels of serum BDNF, MIF and EGF in the two groups were detected by enzyme-linked immunosorbent assay. The clinical symptoms were evaluated by positive and negative symptom scale (PANSS), and the cognitive function was evaluated by cognitive function package consensus Version (MCCB). At the same time, the relationship between the levels of BDNF, MIF and EGF in peripheral blood of schizophrenia and cognitive function was analyzed by Pearson linear correlation. 【Results】The levels of serum BDNF in the control group were significantly higher than those in the observation group, and the levels of serum MIF and EGF were lower than those in the observation group (P<0.05). There was a positive correlation between PAS and NSF (r=286.05,P<0.05). The score of connection test in the control group was lower than that in the observation group, and the symbol coding, visual memory, verbal memory and semantic fluency were higher than those in the observation group (P<0.05). In the observation group, serum MIF level was positively correlated with visual spatial memory (r=0.485,P<0.05), and EGF level was positively correlated with visual spatial memory (r=0.331,P<0.05).【Conclusion】The levels of serum MIF and EGF are closely related to the clinical manifestations and some cognitive impairment of schizophrenic patients, and they are also related to the level of BDNF.
|
|
Received: 06 September 2019
|
|
|
|
|
|
[1] 陈秀红,刘健.精神分裂症患者听觉认知加工的源检测能力研究[J].中华行为医学与脑科学杂志,2016,25(10):909-913.
[2] XIAO W, YE F, LIU C, et al. Cognitive impairment in first-episode drug -nave patients with schizophrenia:Relationshipswith serum concentrations of brain -derived neurotrophic factor and glial cell line -derived neurotrophic factor[J].Prog Neuropsychopharmacol Biol Psychiatry,2017,769(20):163-168.
[3] 袁杰,瞿正万,蔡正宜,等.精神分裂症首次发病未治疗患者血清脑源性神经营养因子水平测定[J].临床精神医学杂志,2015,25(2):105-106.
[4] SIMSEK S,GENÇOSLAN S,YÜKSEL T,et al. Lower brain-derived neurotropic factor levels in untreated adolescents with first-episode psychosis[J].J Clin Psychopharmacol,2015,35(5):596-599.
[5] ALBERT N,MELAU M,JENSEN H,et al.The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders[J].NPJ Schizophr,2017,3(1):34.
[6] 陈经余,赵荣,戴尊孝,等.精神分裂症患者病耻感及其影响因素分析[J].医学临床研究,2015,32(9):1668-1670.
[7] 吴庆,王莹,王莉,等.伴代谢综合征精神分裂症患者前瞻记忆研究[J].中华行为医学与脑科学杂志,2016,25(2):149-152.
[8] CHEN XH.LIU J.Study on source monitoring ability of auditory cog-nitive process in patients with schizophrenia[J].Chin J Behav Med Brain Sci,2016,25(10):909-913.
[9] ZHANG M,DENG KW,GU W,et al.Analysis of cardiovascular risk factors in patients with schizophrenia[J].Chin J Diagnostics(Electronic Edition),2016,4(2):123-128.
[10] XIONG P,ZENG Y,WU Q,et al. Combining serum protein coneentrations to diagnose schizophrenia:a preliminary exploration[J].J Clin Psychiatry,2014,75(8):794-801.
[11] GOLANI I,TADMOR H,BUONANNO A,et al.Disruption of the ErbB Bignaling in adolescence increases striatal dopamine levels and affects learning and hedonic.1ike behavior in the aduh mouse[J].Eur Neuropsychophammcol,2014,24(11):1808-1818. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(9): 1402-1403. |
|
|
|
|
2021, Vol. 38 
